{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T10:46:10Z","timestamp":1791888370464,"version":"4.3.4"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T00:00:00Z","timestamp":1790380800000},"content-version":"vor","delay-in-days":268,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine Case Reports"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.rmcr.2026.102512","type":"journal-article","created":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:27:20Z","timestamp":1790699240000},"page":"102512","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Interstitial lung disease exacerbations following initiation of nerandomilast: A case series"],"prefix":"10.1016","volume":"64","author":[{"given":"Traci N.","family":"Adams","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.rmcr.2026.102512_bib1","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1513\/AnnalsATS.202211-924CME","article-title":"Summary for clinicians: idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults","volume":"20","author":"Herman","year":"2023","journal-title":"Ann. Am. Thorac. Soc."},{"issue":"1","key":"10.1016\/j.rmcr.2026.102512_bib2","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1183\/13993003.00026-2015","article-title":"Pirfenidone for idiopathic pulmonary fibrosis: analysis of pooled data from three multinational phase 3 trials","volume":"47","author":"Noble","year":"2016","journal-title":"Eur. Respir. J."},{"issue":"22","key":"10.1016\/j.rmcr.2026.102512_bib3","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1056\/NEJMoa1402584","article-title":"Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis","volume":"370","author":"Richeldi","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"18","key":"10.1016\/j.rmcr.2026.102512_bib4","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1056\/NEJMoa1908681","article-title":"Nintedanib in progressive fibrosing interstitial lung diseases","volume":"381","author":"Flaherty","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"22","key":"10.1016\/j.rmcr.2026.102512_bib5","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1056\/NEJMoa2503643","article-title":"Nerandomilast in patients with progressive pulmonary fibrosis","volume":"392","author":"Maher","year":"2025","journal-title":"N. Engl. J. Med."},{"issue":"22","key":"10.1016\/j.rmcr.2026.102512_bib6","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1056\/NEJMoa2414108","article-title":"Nerandomilast in patients with idiopathic pulmonary fibrosis","volume":"392","author":"Richeldi","year":"2025","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.rmcr.2026.102512_bib7","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1164\/rccm.201604-0801CI","article-title":"Acute exacerbation of idiopathic pulmonary fibrosis an international working group report","volume":"194","author":"Collard","year":"2016","journal-title":"Am. J. Resp. Crit. Care"},{"issue":"5","key":"10.1016\/j.rmcr.2026.102512_bib8","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1165\/rcmb.2024-0614OC","article-title":"Insights into the cellular and molecular mechanisms behind the antifibrotic effects of nerandomilast","volume":"73","author":"Reininger","year":"2025","journal-title":"Am. J. Resp. Cell Mol."},{"issue":"171","key":"10.1016\/j.rmcr.2026.102512_bib9","article-title":"Phosphodiesterase 4B inhibition: a potential novel strategy for treating pulmonary fibrosis","volume":"32","author":"Kolb","year":"2023","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.rmcr.2026.102512_bib10","article-title":"Extracellular adenosine induces hypersecretion of IL-17A by T-helper 17 cells through the adenosine A2a receptor","volume":"26","author":"Tokano","year":"2022","journal-title":"Brain Behav. Immun-Hl"},{"key":"10.1016\/j.rmcr.2026.102512_bib11","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.bbi.2024.11.013","article-title":"TH17\/Treg lymphocyte balance is regulated by beta adrenergic and cAMP signaling","volume":"123","author":"Lauten","year":"2025","journal-title":"Brain Behav. Immun."},{"issue":"8","key":"10.1016\/j.rmcr.2026.102512_bib12","doi-asserted-by":"crossref","first-page":"4095","DOI":"10.4049\/jimmunol.1301079","article-title":"Cholera toxin directly enhances IL-17A production from human CD4 T cells","volume":"191","author":"Tsai","year":"2013","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.rmcr.2026.102512_bib13","doi-asserted-by":"crossref","first-page":"5125","DOI":"10.7150\/thno.74809","article-title":"Essential role of IL-17 in acute exacerbation of pulmonary fibrosis induced by non-typeable Haemophilus influenzae","volume":"12","author":"Chen","year":"2022","journal-title":"Theranostics"},{"issue":"4","key":"10.1016\/j.rmcr.2026.102512_bib14","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41401-021-00706-4","article-title":"Pirfenidone ameliorates silica-induced lung inflammation and fibrosis in mice by inhibiting the secretion of interleukin-17A","volume":"43","author":"Cao","year":"2022","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.rmcr.2026.102512_bib15","doi-asserted-by":"crossref","first-page":"997","DOI":"10.2147\/DDDT.S288369","article-title":"The effect of nintedanib on T-Cell activation, subsets and functions","volume":"15","author":"Ubieta","year":"2021","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.rmcr.2026.102512_bib16","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.tice.2017.12.008","article-title":"Nintedanib effects on delaying cancer progression and decreasing COX-2 and IL-17 in the prostate anterior lobe in TRAMP mice","volume":"50","author":"Alves","year":"2018","journal-title":"Tissue Cell"}],"container-title":["Respiratory Medicine Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213007126001498?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213007126001498?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T09:56:51Z","timestamp":1791885411000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213007126001498"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":16,"alternative-id":["S2213007126001498"],"URL":"https:\/\/doi.org\/10.1016\/j.rmcr.2026.102512","relation":{},"ISSN":["2213-0071"],"issn-type":[{"value":"2213-0071","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interstitial lung disease exacerbations following initiation of nerandomilast: A case series","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmcr.2026.102512","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102512"}}